Westfield Capital Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Westfield Capital Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-72,774	Closed	-$5.48M	–	257
2020 Q1	$5.48M	Sell	72,774 -3,421	-4%	-$394K	0.05%	192
2019 Q4	$10.5M	Sell	76,195 -31,516	-29%	-$3.83M	0.07%	186
2019 Q3	$12.8M	Buy	107,711 +3,277	+3%	+$457K	0.1%	178
2019 Q2	$14.6M	Buy	104,434 +52,165	+100%	+$9.16M	0.11%	185
2019 Q1	$9.35M	Buy	+52,269	New	+$7.86M	0.07%	199

Other funds holding ORTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Westfield Capital Management's ORTX Position: Q2 2020 in Review

Westfield Capital Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2020, closing a stake of 72,774 shares — an estimated $5.48M sold.

Westfield Capital Management first reported a position in ORTX in Q1 2019 and held it in 5 quarters. The position peaked at $14.6M in Q2 2019. 81 funds tracked by Wall St. Rank hold ORTX as of Q2 2020.

Westfield Capital Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2020 after selling out during the quarter.
Westfield Capital Management sold 72,774 Orchard Therapeutics plc American Depositary Shares shares in Q2 2020, an estimated $5.48M.
Westfield Capital Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2019 and held it in 5 quarters.
Westfield Capital Management's Orchard Therapeutics plc American Depositary Shares position peaked at $14.6M in Q2 2019.
81 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2020.

Based on Westfield Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.